The workplace project – putting learning into practice

We want our education to be impactful, transforming an individual's practice - and through that, the team or service they work within. Intermodule projects are a core part of the education we offer, providing an opportunity to reinforce learning, test new knowledge and skills and improve local services.

Attendees have free reign over their project which must meet a local need, and they present their work back to their peers at module two of the course, and the class chooses a winning project.

We believe that one of the best ways to learn something is from others who have already learned it. We'd encourage you to have a look through the extensive 'back catalogue' of previous projects to find one addressing a similar need to the one in your area, or to learn how others have overcome obstacles you might face.

'Workplace projects give a space for the MasterClass's challenging learning outcomes to change things at a grassroots level and then to keep changing them - and this is what makes a difference to people with Parkinson’s.’
Dr Peter Fletcher, academic director & founder of Parkinson's Academy


Spotlight Projects


Multiple Sclerosis relapses: improving patient education
By Nicole Japzon, Neurology Physician Associate Band 7, University College London Hospitals NHS Foundation Trust & Flordeliza Madriaga, MS Clinical Nurse Specialist, University College London Hospitals NHS Foundation Trust
Patient engagement to inform changes in Multiple Sclerosis (MS) services in City and Hackney August 2022
By Sarah German, MS Specialist Practitioner Band 7, Homerton University Hospital NHS Foundation Trust
Improvement of bone health assessment in idiopathic Parkinson's disease
By Dr Joshua Drake, Geriatric Speciality Doctor, Portsmouth Hospitals NHS Trust

All projects


Showing 81-90 of 101 projects

Review of Parkinson’s patients on dopamine agonist agents
By Dr Elizabeth Castaneda-Caicedo, Speciality Doctor, Great Western Hospital
Dopamine Agonist Monitoring
By Belinda Kessel, Parkinson's Specialist and Geriatrician, Princess Royal Hospital, University Hospital Farnborough
Prescribing and administering Parkinson’s disease drugs in patients with hip fractures: re-audit
By A. Chatterjee, R. Ganapathy, J. Bowen, S. Logan, Royal Berkshire NHS Foundation Trust
Time from ‘treatment decision’ to ‘actual start of DMT’ in MS – a local clinical survey
By Dr Bindu Yoga, Consultant Neurologist, Mid Yorkshire Hospitals NHS Trust
Audit of safe monitoring of MS patients on natalizumab
By Dr Lewis Kass-lliyya, Dr Jennifer Hosty and Dr Simon Bell, Royal Hallamshire Hospital (Supervisor: Dr David Paling)
Fingolimod safety considerations in real-world practice: fingolimod-associated macular oedema (FAME)
By Dr Paul Gallagher and Dr Sarah-Jane Martin, Institute of Neurological Sciences, Glasgow
Listeriosis prevention in alemtuzumab treated patients
By Dr Rachelle Shafei, Clinical Research Fellow, University College London